"Time for a More Effective Tuberculosis Vaccine"

Tuberculosis (TB) continues to be a major global health concern, with over 10 million people falling ill and 1.3 million dying from the disease in 2022. While the existing BCG vaccine and antibiotic treatments have limitations, new TB vaccines are showing promise in phase 3 trials, offering hope for preventing TB in adolescents and adults. The development of these vaccines comes after decades of neglect and renewed efforts to eradicate TB, with the potential to save hundreds of thousands of lives and make a significant impact on a disease that has plagued humanity for millennia.